Market open
ProPhase Labs/$PRPH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About ProPhase Labs
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
Ticker
$PRPH
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
96
ISIN
US74345W1080
Website
ProPhase Labs Metrics
BasicAdvanced
$14M
-
-$2.61
-0.55
-
Price and volume
Market cap
$14M
Beta
-0.55
52-week high
$5.45
52-week low
$0.22
Average daily volume
1.7M
Financial strength
Current ratio
0.953
Quick ratio
0.645
Long term debt to equity
244.866
Total debt to equity
334.19
Interest coverage (TTM)
-11.53%
Management effectiveness
Return on assets (TTM)
-31.13%
Return on equity (TTM)
-174.58%
Valuation
Price to revenue (TTM)
1.028
Price to book
1.38
Price to tangible book (TTM)
-1.33
Price to free cash flow (TTM)
-0.377
Growth
Revenue change (TTM)
-80.65%
Earnings per share change (TTM)
167.39%
3-year revenue growth (CAGR)
-55.92%
3-year earnings per share growth (CAGR)
87.53%
What the Analysts think about ProPhase Labs
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for ProPhase Labs stock.
ProPhase Labs Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
ProPhase Labs Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
ProPhase Labs News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for ProPhase Labs stock?
ProPhase Labs (PRPH) has a market cap of $14M as of May 14, 2025.
What is the P/E ratio for ProPhase Labs stock?
The price to earnings (P/E) ratio for ProPhase Labs (PRPH) stock is 0 as of May 14, 2025.
Does ProPhase Labs stock pay dividends?
No, ProPhase Labs (PRPH) stock does not pay dividends to its shareholders as of May 14, 2025.
When is the next ProPhase Labs dividend payment date?
ProPhase Labs (PRPH) stock does not pay dividends to its shareholders.
What is the beta indicator for ProPhase Labs?
ProPhase Labs (PRPH) has a beta rating of -0.55. This means that it has an inverse relation to market volatility.